RN-1734 is primarily used as a selective antagonist for the TRPV4 ion channel, making it a valuable tool in scientific research focused on understanding cellular responses involved in pain, inflammation, and osmotic regulation. It is commonly applied in studies related to sensory neuron activity, where modulation of TRPV4 helps investigate mechanisms underlying thermal hyperalgesia and mechanical allodynia. Researchers also utilize RN-1734 in models of lung injury and edema to examine the role of TRPV4 in endothelial permeability and vascular function. Due to its ability to cross the blood-brain barrier, it supports investigations into central nervous system disorders involving neuroinflammation and neuronal excitability. Its selectivity makes it suitable for pharmacological profiling and target validation in early-stage drug development.